What is Canndoc?
Canndoc, formerly InterCure Ltd., is an Israeli company dedicated to the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-derived products for medical applications. Headquartered in Herzliya, Israel, the company's operations span both domestic and international markets. Its product portfolio includes dried cannabis inflorescences and cannabis extract mixed with oil. Beyond its core cannabis business, Canndoc also engages in investments within the biomed sector, indicating a diversified approach to healthcare innovation. The company was incorporated in 1994.
How much funding has Canndoc raised?
Canndoc has raised a total of $18M across 1 funding round:
Other Financing Round
$18M
Other Financing Round (2024): $18M, investors not publicly disclosed
What's next for Canndoc?
The recent major strategic investment signals Canndoc's readiness for significant expansion and market penetration. This influx of capital, part of a larger enterprise-level funding round, is likely to fuel advancements in product development, enhance cultivation and production capabilities, and broaden its distribution network. Canndoc's focus on pharmaceutical-grade products positions it to capitalize on the growing global demand for regulated medical cannabis. Future endeavors may include further R&D in cannabis-based therapeutics and strategic partnerships to solidify its market leadership.
See full Canndoc company page
